Table 3

Summary statistics for duration (days) from randomisation to the last patient reported symptoms of nausea, vomiting, fever, defined as ≥38°C, and abdominal pain, for each treatment group (n, mean [SD], median [IQR] and min–max)

GroupNMean (SD)Median (IQR)Min–Max
Nausea
 Control132.1 (2.5)1 (0–3)0–8
 Enterosgel122.2 (2.4)1 (1–4)0–8
Vomiting
 Control40.8 (1.0)1 (0–2)0–2
 Enterosgel40.5 (0.6)1 (0–1)0–1
Fever
 Control213.8 (2.0)4 (3–5)0–7
 Enterosgel263.0 (2.6)2 (1–5)0–8
Abdominal pain
 Control90.2 (0.4)0 (0–0)0–1
 Enterosgel10.0 (0.0)0 (0-0)0